Skip to content Home / Companies / XAIR XAI
Beyond Air, Inc. (XAIR) XNAS SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Net insider buying (90d)
Latest XAIR Insider Trades
About Beyond Air, Inc. (XAIR) Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.
Headquarters GARDEN CITY, NY
Employees 54
Listed 2016
Exchange XNAS https://www.beyondair.net SEC filings for XAIR on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market purchase 6 117,186 $225K
XAIR Insider Transactions (Form 4) 215 23 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
Date Insider Transaction Security Shares Price Value Jul 29, 2026 RG Robert Scott Goodman - Officer Open-market purchase Common Stock 34,722
Recent XAIR Form 8-K Filings 5
XAIR Insider Trading - FAQ
What is the latest insider trade for XAIR? Beyond Air, Inc. (XAIR) had 2 insider filings in the last 90 days, with the most recent on 2026-07-31. The full record for XAIR runs to 23 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying XAIR stock? 6 insider purchases of XAIR were filed in the last 90 days, totaling $225K.
How many insiders are selling XAIR stock? No insider sales of XAIR were filed in the last 90 days.
Where can I see XAIR SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks XAIR Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow XAIR insider buys? Create a free InsiderAlpha account and press Watch on this page to add XAIR to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track XAIR insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free - Officer
Open-market purchase 34,722 sh
RC Robert Carey - Director Open-market purchase $745K
Sep 26, 2024
Market cap $3.03M
P/E ratio -
Dividend yield -
Average volume 198.8K
52 week high $55.60
52 week low $3.06
Today's high $3.18
Today's low $3.08
Open $3.13
Volume 16.6K
Previous close $3.08
Shares outstanding 984.4K Market cap
$3.03M
54 employees
XAIR Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
100% Buying 0% Selling
6 insider purchases totaling $225K against 0 sales totaling $0.
Most-Active XAIR Insiders - Last 90 Days 10 Jan 5, 2026 DM Daniel J. Moorhead - Officer Grant or award Stock Option (right to buy) 70,000 - -
Nov 4, 2025 YL Yoori Lee - Director Derivative Stock Options (Right to buy) 2,250 - -
Nov 4, 2025 YL Yoori Lee - Director Grant or award Stock Options (Right to buy) 2,250 - -
Nov 4, 2025 YL Yoori Lee - Director Derivative Stock Options (Right to buy) 2,000 - -
Nov 4, 2025 YL Yoori Lee - Director Grant or award Stock Options (Right to buy) 2,000 - -
Nov 4, 2025 YL Yoori Lee - Director Derivative Stock Options (Right to buy) 1,500 - -
Nov 4, 2025 YL Yoori Lee - Director Grant or award Stock Options (Right to buy) 1,500 - -
Nov 4, 2025 YL Yoori Lee - Director Derivative Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 YL Yoori Lee - Director Derivative Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 YL Yoori Lee - Director Derivative Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 YL Yoori Lee - Director Grant or award Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 YL Yoori Lee - Director Grant or award Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 YL Yoori Lee - Director Grant or award Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 YL Yoori Lee - Director Derivative Stock Options (Right to buy) 750 - -
Nov 4, 2025 YL Yoori Lee - Director Grant or award Stock Options (Right to buy) 750 - -
Nov 4, 2025 YL Yoori Lee - Director Derivative Stock Options (Right to buy) 3,750 - -
Nov 4, 2025 YL Yoori Lee - Director Grant or award Stock Options (Right to buy) 3,750 - -
Nov 4, 2025 MG Michael A. Gaul - Officer Derivative Stock Options (Right to buy) 17,500 - -
Nov 4, 2025 MG Michael A. Gaul - Officer Grant or award Stock Options (Right to buy) 17,500 - -
Nov 4, 2025 MG Michael A. Gaul - Officer Derivative Stock Options (Right to buy) 8,500 - -
Nov 4, 2025 MG Michael A. Gaul - Officer Grant or award Stock Options (Right to buy) 8,500 - -
Nov 4, 2025 MG Michael A. Gaul - Officer Derivative Stock Options (Right to buy) 3,500 - -
Nov 4, 2025 MG Michael A. Gaul - Officer Grant or award Stock Options (Right to buy) 3,500 - -
Nov 4, 2025 MG Michael A. Gaul - Officer Derivative Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 MG Michael A. Gaul - Officer Grant or award Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 MG Michael A. Gaul - Officer Derivative Stock Options (Right to buy) 500 - -
Nov 4, 2025 MG Michael A. Gaul - Officer Grant or award Stock Options (Right to buy) 500 - -
Nov 4, 2025 MG Michael A. Gaul - Officer Derivative Stock Options (Right to buy) 2,000 - -
Nov 4, 2025 MG Michael A. Gaul - Officer Grant or award Stock Options (Right to buy) 2,000 - -
Nov 4, 2025 MG Michael A. Gaul - Officer Derivative Stock Options (Right to buy) 20,000 - -
Nov 4, 2025 MG Michael A. Gaul - Officer Grant or award Stock Options (Right to buy) 20,000 - -
Nov 4, 2025 RC Robert Carey - Director Derivative Stock Options (Right to buy) 4,500 - -
Nov 4, 2025 RC Robert Carey - Director Grant or award Stock Options (Right to buy) 4,500 - -
Nov 4, 2025 RC Robert Carey - Director Derivative Stock Options (Right to buy) 2,000 - -
Nov 4, 2025 RC Robert Carey - Director Grant or award Stock Options (Right to buy) 2,000 - -
Nov 4, 2025 RC Robert Carey - Director Derivative Stock Options (Right to buy) 1,500 - -
Nov 4, 2025 RC Robert Carey - Director Grant or award Stock Options (Right to buy) 1,500 - -
Nov 4, 2025 RC Robert Carey - Director Derivative Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 RC Robert Carey - Director Derivative Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 RC Robert Carey - Director Derivative Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 RC Robert Carey - Director Grant or award Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 RC Robert Carey - Director Grant or award Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 RC Robert Carey - Director Grant or award Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 RC Robert Carey - Director Derivative Stock Options (Right to buy) 50 - -
Nov 4, 2025 RC Robert Carey - Director Grant or award Stock Options (Right to buy) 50 - -
Nov 4, 2025 RC Robert Carey - Director Derivative Stock Options (Right to buy) 10,000 - -
Nov 4, 2025 RC Robert Carey - Director Grant or award Stock Options (Right to buy) 10,000 - -
Nov 3, 2025 SL Steven A. Lisi - Officer Derivative Warrants to purchase Common Stock 164,778 - -
Nov 3, 2025 SL Steven A. Lisi - Officer Grant or award Warrants to purchase Common Stock 164,778 - -
Nov 4, 2025 EL Erick Lucera - Director Grant or award Stock Options (Right to buy) 2,000 - -
Nov 4, 2025 EL Erick Lucera - Director Derivative Stock Options (Right to buy) 1,500 - -
Nov 4, 2025 EL Erick Lucera - Director Grant or award Stock Options (Right to buy) 1,500 - -
Nov 4, 2025 EL Erick Lucera - Director Derivative Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 EL Erick Lucera - Director Derivative Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 EL Erick Lucera - Director Derivative Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 EL Erick Lucera - Director Grant or award Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 EL Erick Lucera - Director Grant or award Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 EL Erick Lucera - Director Grant or award Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 EL Erick Lucera - Director Derivative Stock Options (Right to buy) 1,000 - -
Nov 4, 2025 EL Erick Lucera - Director Grant or award Stock Options (Right to buy) 1,000 - -
Nov 4, 2025 EL Erick Lucera - Director Derivative Stock Options (Right to buy) 3,750 - -
Nov 4, 2025 EL Erick Lucera - Director Grant or award Stock Options (Right to buy) 3,750 - -
Nov 4, 2025 EL Erick Lucera - Director Derivative Stock Options (Right to buy) 2,250 - -
Nov 4, 2025 EL Erick Lucera - Director Grant or award Stock Options (Right to buy) 2,250 - -
Nov 4, 2025 EL Erick Lucera - Director Derivative Stock Options (Right to buy) 2,000 - -
Nov 4, 2025 WF William P. Forbes - Director Derivative Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 WF William P. Forbes - Director Grant or award Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 WF William P. Forbes - Director Grant or award Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 WF William P. Forbes - Director Grant or award Stock Options (Right to buy) 400 - -
Nov 4, 2025 WF William P. Forbes - Director Derivative Stock Options (Right to buy) 1,500 - -
Nov 4, 2025 WF William P. Forbes - Director Grant or award Stock Options (Right to buy) 1,500 - -
Nov 4, 2025 WF William P. Forbes - Director Derivative Stock Options (Right to buy) 2,000 - -
Nov 4, 2025 WF William P. Forbes - Director Grant or award Stock Options (Right to buy) 2,000 - -
Nov 4, 2025 WF William P. Forbes - Director Derivative Stock Options (Right to buy) 2,250 - -
Nov 4, 2025 WF William P. Forbes - Director Grant or award Stock Options (Right to buy) 2,250 - -
Nov 4, 2025 WF William P. Forbes - Director Derivative Stock Options (Right to buy) 3,750 - -
Nov 4, 2025 WF William P. Forbes - Director Grant or award Stock Options (Right to buy) 3,750 - -
Nov 4, 2025 WF William P. Forbes - Director Derivative Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 WF William P. Forbes - Director Derivative Stock Options (Right to buy) 1,250 - -
Nov 4, 2025 WF William P. Forbes - Director Grant or award Stock Options (Right to buy) 1,250 - -
Jul 21, 2025 SL Steven A. Lisi - Officer Open-market purchase Common Stock 6,000 $64.97 $19K
Nov 22, 2024 YL Yoori Lee - Director Derivative Stock Options (Right to buy) 45,000 - -
Nov 22, 2024 YL Yoori Lee - Director Grant or award Stock Options (Right to buy) 45,000 - -
Nov 22, 2024 YL Yoori Lee - Director Derivative Stock Options (Right to buy) 40,000 - -
Nov 22, 2024 YL Yoori Lee - Director Grant or award Stock Options (Right to buy) 40,000 - -
Nov 22, 2024 YL Yoori Lee - Director Derivative Stock Options (Right to buy) 30,000 - -
Nov 22, 2024 YL Yoori Lee - Director Grant or award Stock Options (Right to buy) 30,000 - -
Nov 22, 2024 YL Yoori Lee - Director Derivative Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 YL Yoori Lee - Director Grant or award Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 YL Yoori Lee - Director Derivative Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 YL Yoori Lee - Director Grant or award Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 YL Yoori Lee - Director Derivative Stock Options (Right to buy) 15,000 - -
Nov 22, 2024 YL Yoori Lee - Director Grant or award Stock Options (Right to buy) 15,000 - -
Nov 22, 2024 YL Yoori Lee - Director Derivative Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 YL Yoori Lee - Director Grant or award Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 EL Erick Lucera - Director Derivative Stock Options (Right to buy) 45,000 - -
Nov 22, 2024 EL Erick Lucera - Director Grant or award Stock Options (Right to buy) 45,000 - -
Nov 22, 2024 EL Erick Lucera - Director Derivative Stock Options (Right to buy) 40,000 - -
Nov 22, 2024 EL Erick Lucera - Director Grant or award Stock Options (Right to buy) 40,000 - -
Nov 22, 2024 EL Erick Lucera - Director Derivative Stock Options (Right to buy) 30,000 - -
Nov 22, 2024 EL Erick Lucera - Director Grant or award Stock Options (Right to buy) 30,000 - -
Nov 22, 2024 EL Erick Lucera - Director Derivative Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 EL Erick Lucera - Director Grant or award Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 EL Erick Lucera - Director Derivative Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 EL Erick Lucera - Director Grant or award Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 EL Erick Lucera - Director Derivative Stock Options (Right to buy) 20,000 - -
Nov 22, 2024 EL Erick Lucera - Director Grant or award Stock Options (Right to buy) 20,000 - -
Nov 22, 2024 EL Erick Lucera - Director Derivative Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 EL Erick Lucera - Director Grant or award Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 WF William P. Forbes - Director Derivative Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 WF William P. Forbes - Director Grant or award Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 WF William P. Forbes - Director Derivative Stock Options (Right to buy) 8,000 - -
Nov 22, 2024 WF William P. Forbes - Director Grant or award Stock Options (Right to buy) 8,000 - -
Nov 22, 2024 WF William P. Forbes - Director Derivative Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 WF William P. Forbes - Director Grant or award Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 WF William P. Forbes - Director Derivative Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 WF William P. Forbes - Director Grant or award Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 WF William P. Forbes - Director Derivative Stock Options (Right to buy) 30,000 - -
Nov 22, 2024 WF William P. Forbes - Director Grant or award Stock Options (Right to buy) 30,000 - -
Nov 22, 2024 WF William P. Forbes - Director Derivative Stock Options (Right to buy) 40,000 - -
Nov 22, 2024 WF William P. Forbes - Director Grant or award Stock Options (Right to buy) 40,000 - -
Nov 22, 2024 WF William P. Forbes - Director Derivative Stock Options (Right to buy) 45,000 - -
Nov 22, 2024 WF William P. Forbes - Director Grant or award Stock Options (Right to buy) 45,000 - -
Nov 22, 2024 RB Ron Bentsur - Director Derivative Stock Options (Right to buy) 45,000 - -
Nov 22, 2024 RB Ron Bentsur - Director Grant or award Stock Options (Right to buy) 45,000 - -
Nov 22, 2024 RB Ron Bentsur - Director Derivative Stock Options (Right to buy) 40,000 - -
Nov 22, 2024 RB Ron Bentsur - Director Grant or award Stock Options (Right to buy) 40,000 - -
Nov 22, 2024 RB Ron Bentsur - Director Derivative Stock Options (Right to buy) 30,000 - -
Nov 22, 2024 RB Ron Bentsur - Director Grant or award Stock Options (Right to buy) 30,000 - -
Nov 22, 2024 RB Ron Bentsur - Director Derivative Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 RB Ron Bentsur - Director Grant or award Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 RB Ron Bentsur - Director Derivative Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 RB Ron Bentsur - Director Grant or award Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 RB Ron Bentsur - Director Derivative Stock Options (Right to buy) 24,000 - -
Nov 22, 2024 RB Ron Bentsur - Director Grant or award Stock Options (Right to buy) 24,000 - -
Nov 22, 2024 SL Steven A. Lisi - Officer Derivative Stock Options (Right to buy) 950,000 - -
Nov 22, 2024 SL Steven A. Lisi - Officer Grant or award Stock Options (Right to buy) 950,000 - -
Nov 22, 2024 SL Steven A. Lisi - Officer Derivative Stock Options (Right to buy) 800,000 - -
Nov 22, 2024 SL Steven A. Lisi - Officer Grant or award Stock Options (Right to buy) 800,000 - -
Nov 22, 2024 SL Steven A. Lisi - Officer Derivative Stock Options (Right to buy) 280,000 - -
Nov 22, 2024 SL Steven A. Lisi - Officer Grant or award Stock Options (Right to buy) 280,000 - -
Nov 22, 2024 SL Steven A. Lisi - Officer Derivative Stock Options (Right to buy) 200,000 - -
Nov 22, 2024 SL Steven A. Lisi - Officer Grant or award Stock Options (Right to buy) 200,000 - -
Nov 22, 2024 SL Steven A. Lisi - Officer Derivative Stock Options (Right to buy) 70,000 - -
Nov 22, 2024 SL Steven A. Lisi - Officer Grant or award Stock Options (Right to buy) 70,000 - -
Nov 22, 2024 SL Steven A. Lisi - Officer Derivative Stock Options (Right to buy) 250,000 - -
Nov 22, 2024 SL Steven A. Lisi - Officer Grant or award Stock Options (Right to buy) 250,000 - -
Nov 22, 2024 SL Steven A. Lisi - Officer Derivative Stock Options (Right to buy) 400,000 - -
Nov 22, 2024 SL Steven A. Lisi - Officer Grant or award Stock Options (Right to buy) 400,000 - -
Nov 22, 2024 RC Robert Carey - Director Derivative Stock Options (Right to buy) 90,000 - -
Nov 22, 2024 RC Robert Carey - Director Grant or award Stock Options (Right to buy) 90,000 - -
Nov 22, 2024 RC Robert Carey - Director Derivative Stock Options (Right to buy) 40,000 - -
Nov 22, 2024 RC Robert Carey - Director Grant or award Stock Options (Right to buy) 40,000 - -
Nov 22, 2024 RC Robert Carey - Director Derivative Stock Options (Right to buy) 30,000 - -
Nov 22, 2024 RC Robert Carey - Director Grant or award Stock Options (Right to buy) 30,000 - -
Nov 22, 2024 RC Robert Carey - Director Derivative Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 RC Robert Carey - Director Grant or award Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 RC Robert Carey - Director Derivative Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 RC Robert Carey - Director Grant or award Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 RC Robert Carey - Director Derivative Stock Options (Right to buy) 1,000 - -
Nov 22, 2024 RC Robert Carey - Director Grant or award Stock Options (Right to buy) 1,000 - -
Nov 22, 2024 RC Robert Carey - Director Derivative Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 RC Robert Carey - Director Grant or award Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 MG Michael A. Gaul - Officer Derivative Stock Options (Right to buy) 350,000 - -
Nov 22, 2024 MG Michael A. Gaul - Officer Grant or award Stock Options (Right to buy) 350,000 - -
Nov 22, 2024 MG Michael A. Gaul - Officer Derivative Stock Options (Right to buy) 170,000 - -
Nov 22, 2024 MG Michael A. Gaul - Officer Grant or award Stock Options (Right to buy) 170,000 - -
Nov 22, 2024 MG Michael A. Gaul - Officer Derivative Stock Options (Right to buy) 70,000 - -
Nov 22, 2024 MG Michael A. Gaul - Officer Grant or award Stock Options (Right to buy) 70,000 - -
Nov 22, 2024 MG Michael A. Gaul - Officer Derivative Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 MG Michael A. Gaul - Officer Grant or award Stock Options (Right to buy) 25,000 - -
Nov 22, 2024 MG Michael A. Gaul - Officer Derivative Stock Options (Right to buy) 10,000 - -
Nov 22, 2024 MG Michael A. Gaul - Officer Grant or award Stock Options (Right to buy) 10,000 - -
Nov 22, 2024 MG Michael A. Gaul - Officer Derivative Stock Options (Right to buy) 40,000 - -
Nov 22, 2024 MG Michael A. Gaul - Officer Grant or award Stock Options (Right to buy) 40,000 - -
Sep 26, 2024 RC Robert Carey - Director Open-market purchase Common Stock 1,476,626 $201.72 $745K
Sep 26, 2024 RC Robert Carey - Director Open-market purchase Pre-funded Warrants to purchase Common Stock 26,142 - -
Sep 26, 2024 RC Robert Carey - Director Open-market purchase Pre-funded Warrants to purchase Common Stock 480,179 - -
Sep 26, 2024 RC Robert Carey - Director Open-market purchase Warrants to purchase Common Stock 102,382 - -
Sep 26, 2024 RC Robert Carey - Director Open-market purchase Warrants to purchase Common Stock 1,880,565 - -
Sep 27, 2024 RC Robert Carey - Director Other Warrants to purchase Common Stock 9,886,633 - -
Sep 26, 2024 SL Steven A. Lisi - Officer Open-market purchase Common Stock 1,476,626 $201.72 $745K
Sep 26, 2024 SL Steven A. Lisi - Officer Open-market purchase Pre-funded Warrants to purchase Common Stock 506,321 - -
Sep 26, 2024 SL Steven A. Lisi - Officer Open-market purchase Warrants to purchase Common Stock 1,982,947 - -
Sep 27, 2024 SL Steven A. Lisi - Officer Other Warrants to purchase Common Stock 3,295,544 - -
$XLO
Xilio Therapeutics, Inc.
$BBNX
Beta Bionics, Inc.
